DOI: https://dx.doi.org/10.18203/2394-6040.ijcmph20222583
Published: 2022-09-28

Dravet syndrome in a 3-year-old pediatric patient: case report

Shailaja K., Nissi L., Tamil Arasi A.

Abstract


Dravet syndrome (DS) is a severe form of epilepsy that occurs during the first year of life. This is caused by mutations in the voltage-gated sodium channel and characterized by frequent, prolonged seizures often triggered by high body temperature (hyperthermia), developmental delay, ataxia, hypotonia, sleep disturbances which is treated by multiple antiepileptic drugs. In this case report, we will discuss a 3 years old male pediatric patient who presented with complaints of vomiting and lethargies followed by seizures and has been diagnosed with DS since the age of 6 months. He was given with multiple antiepileptic drugs and other drugs for his symptomatic management which resulted in a major drug interaction. From this case report, we will get a clear picture necessitating continuous monitoring in case of polypharmacy.


Keywords


DS, Pediatric, Electroencephalogram, Antiepileptic drugs, Drug interactions, Polypharmacy

Full Text:

PDF

References


Anwar A, Saleem S, Patel UK, Arumaithurai K, Malik P. Dravet syndrome: An overview. Cureus. 2019;11(6):e5006.

Wu YW, Sullivan J, McDaniel SS, Meisler MH, Walsh EM, Li SX et al. Incidence of Dravet syndrome in a US population. Pediatrics. 2015;136(5):e1310-5.

Isom LL, Knupp KG. Dravet syndrome: Novel approaches for the most common genetic epilepsy. Neurotherapeutics. 2021;18(3):1524-34.

Knupp KG, Wirrell EC. Treatment strategies for Dravet syndrome. CNS Drugs. 2018;32(4):335-50.

De Liso P, Pironi V, Mastrangelo M, Battaglia D, Craiu D, Trivisano M et al. Fatal status epilepticus in Dravet Syndrome. Brain Sci. 2020;10(11):889.

Kapoor D, Anand A, Sharma S, Mukherjee SB, Marini C, Mei D, et al. Dravet syndrome: A case series. Indian J Pediatr. 2021;88(1):82.

Ding J, Wang L, Jin Z, Qiang Y, Li W, Wang Y et al. Do all roads lead to Rome? Genes causing Dravet syndrome and Dravet syndrome-like phenotypes. Front Neurol. 2022;13:832380.

Lopez-Santiago L, Isom LL. Dravet syndrome: A developmental and epileptic encephalopathy. Epilepsy Curr. 2019;19(1):51-3.

Paprocka J, Lewandowska A, Zieliński P, Kurczab B, Emich-Widera E, Mazurczak T. Dravet Syndrome-the Polish family’s perspective study. J Clin Med. 2021;10(9):1903.

Strzelczyk A, Schubert-Bast S. A practical guide to the treatment of Dravet syndrome with anti-seizure medication. CNS Drugs. 2022;36(3):217-37.

Wirrell EC. Treatment of Dravet syndrome. Can J Neurol Sci. 2016;43(S3):S13-8.

Wheless JW, Fulton SP, Mudigoudar BD. Dravet syndrome: A review of current management. Pediatr Neurol. 2020;107:28-40.

Strzelczyk A, Schubert-Bast S. A practical guide to the treatment of Dravet syndrome with anti-seizure medication. CNS Drugs. 2022;36(3):217-37.

Incorpora G. Dravet syndrome. Ital J Pediatr. 2009;35(1):27.

Wong-Kisiel LC, Nickels K. Electroencephalogram of age-dependent epileptic encephalopathies in infancy and early childhood. Epilepsy Res Treat. 2013;743203.

Licheni SH, Mcmahon JM, Schneider AL, Davey MJ, Scheffer IE. Sleep problems in Dravet syndrome: a modifiable comorbidity. Dev Med Child Neurol. 2018;60(2):192-8.

Maganti RK, Jones MV. Untangling a web: Basic mechanisms of the complex interactions between sleep, circadian rhythms, and epilepsy. Epilepsy Curr. 2021;21(2):105-10.

Myers KA, Davey MJ, Ching M, Ellis C, Grinton BE, Roten A et al. Randomized controlled trial of melatonin for sleep disturbance in Dravet syndrome: The DREAMS study. J Clin Sleep Med. 2018;14(10):1697-704.